This announcement is a separate document:
Delta-Fly Pharma：DFP-14927臨床第１相試験に係る抄録をASCOへ提出したことに関するお知らせ
Delta-Fly Pharma: Notice regarding submission of abstracts relating to the DFP-14927 clinical phase 1 trial to ASCO
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.